These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1663250)

  • 21. Effect of flosequinan upon isoenzymes of phosphodiesterase from guinea-pig cardiac and vascular smooth muscle.
    Frodsham G; Jones RB
    Eur J Pharmacol; 1992 Feb; 211(3):383-91. PubMed ID: 1319914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma.
    Nicholson CD; Shahid M; Bruin J; Barron E; Spiers I; de Boer J; van Amsterdam RG; Zaagsma J; Kelly JJ; Dent G
    J Pharmacol Exp Ther; 1995 Aug; 274(2):678-87. PubMed ID: 7636728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific cyclic nucleotide phosphodiesterase inhibitors differently modulate contractile kinetics in airway smooth muscle.
    Rousseau E; Dostie J; Taoudi-Benchekroun M; Cadieux A; Beaudry C; Lugnier C
    Can J Physiol Pharmacol; 1995 Dec; 73(12):1784-94. PubMed ID: 8834493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
    Raeburn D; Karlsson JA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C; Schoeffter P; Le Bec A; Strouthou E; Stoclet JC
    Biochem Pharmacol; 1986 May; 35(10):1743-51. PubMed ID: 2423089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization.
    Rabe KF; Tenor H; Dent G; Schudt C; Liebig S; Magnussen H
    Am J Physiol; 1993 May; 264(5 Pt 1):L458-64. PubMed ID: 7684572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.
    Beavo JA; Reifsnyder DH
    Trends Pharmacol Sci; 1990 Apr; 11(4):150-5. PubMed ID: 2159198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
    Lugnier C; Schini VB
    Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic nucleotide phosphodiesterase isoenzymes and asthma--outstanding issues.
    Nicholson CD
    Agents Actions Suppl; 1993; 43():3-12. PubMed ID: 8396317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta.
    Lindgren S; Rascón A; Andersson KE; Manganiello V; Degerman E
    Biochem Pharmacol; 1991 Jul; 42(3):545-52. PubMed ID: 1650216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary identification and role of phosphodiesterase isozymes in human basophils.
    Peachell PT; Undem BJ; Schleimer RP; MacGlashan DW; Lichtenstein LM; Cieslinski LB; Torphy TJ
    J Immunol; 1992 Apr; 148(8):2503-10. PubMed ID: 1373172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.
    Dousa TP
    Kidney Int; 1999 Jan; 55(1):29-62. PubMed ID: 9893113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.
    Reeves ML; Leigh BK; England PJ
    Biochem J; 1987 Jan; 241(2):535-41. PubMed ID: 3036066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular cardiopharmacology of selective inhibitors of cyclic nucleotide phosphodiesterase isozymes].
    Tanaka T; Mukai J; Naka M
    Nihon Yakurigaku Zasshi; 1992 Sep; 100(3):249-58. PubMed ID: 1328001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro.
    Stief CG; Taher A; Truss M; Becker AJ; Schulz-Knappe P; Meyer M; Uckert S; Forssmann WG; Jonas U
    Urol Int; 1995; 55(4):183-9. PubMed ID: 8588263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N; Lugnier C; Stoclet JC
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and pharmacological characterization of cyclic nucleotide phosphodiesterase in airway epithelium.
    Rousseau E; Gagnon J; Lugnier C
    Mol Cell Biochem; 1994 Nov; 140(2):171-5. PubMed ID: 7898488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.